BMT Tandem "Scientific" Meeting
Ballroom I-J (Salt Palace Convention Center)
Chairs:
Robert Frank Cornell, MD
and
Bipin Savani, MD
Summary:
Abstracts: #2828, 2084, 2352, 1759, 2483, 2837, 1989, 2544
A Population-Based Cohort Study of Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Non -Malignant Conditions
Adam Stuart Nelson, MD, Sydney Children's Hospital;
Tracey Anne O'Brien, MD, Ctr Children's Cancer & Blood Disorders;
Renate Thielbeer, BSc, Children's Cancer Institute Australia for Medical Research;
Claire Vajdic, PhD, Adult Cancer Program;
Dr Anthony Dodds, MB BS FRACP FRCPA, St Vincents Hospital;
Leonie Wilcox, St Vincent's Hospital;
Leslie J Ashton, PhD, Molecular Epidemiology Group, Children’s Cancer Institute Australia for Medical Research
A Cross-Sectional Analysis of Influential Factors On Health-Related Quality of Life in Long-Term Survivors After Hematopoietic Stem Cell Transplantation
Yuki Asano-Mori, MD, PhD, Toranomon Hospital;
Madoka Narita, Toranomon Hospital;
Rumiko Tsuchihashi, Toranomon Hospital;
Hikari Ota, MD, Toranomon Hospital;
Aya Nishida, MD, Toranomon Hospital;
Kazuya Ishiwata, MD, Toranomon Hospital;
Masanori Tsuji, MD, Toranomon Hospital;
Hisashi Yamamoto, MD, Toranomon Hospital;
Go Yamamoto, MD, PhD, Toranomon Hospital;
Naoyuki Uchida, MD, PhD, Toranomon Hospital;
Koji Izutsu, MD, PhD, Toranomon Hospital;
Akiko Yoneyama, MD, PhD, Toranomon Hospital;
Shigeyoshi Makino, MD, PhD, Toranomon Hospital;
Shuichi Taniguchi, MD, PhD, Toranomon Hospital
Late Mortality and Causes of Death Among Long-Term Survivors After Allogeneic Stem Cell Transplantation
Yoshiko Atsuta, MD, PhD, Nagoya University Graduate School of Medicine;
Hideki Nakasone, MD, PhD, Saitama Medical Center, Jichi Medical University;
Saiko Kurosawa, MD, National Cancer Center Hospital;
Kumi Oshima, MD, PhD, St. Luke's International Hospital;
Rika Sakai, MD, PhD, Kanagawa Cancer Center;
Kazuteru Ohashi, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center;
Takahiro Fukuda, MD, PhD, National Cancer Center Hospital;
Satoshi Takahashi, MD, PhD, The Institute of Medical Science, The University of Tokyo;
Takehiko Mori, MD, PhD, Keio University School of Medicine;
Yasuo Morishima, MD, PhD, Aichi Cancer Center Research Institute;
Koji Kato, MD, PhD, Japanese Red Cross Nagoya First Hospital;
Hiromasa Yabe, MD, PhD, Tokai University School of Medicine;
Hisashi Sakamaki, MD, PhD, Tokyo Metropolitan Cancer and Infectious diseases Center;
Shuichi Taniguchi, MD, PhD, Toranomon Hospital
Post-Transplant Pulmonary Function Abnormalities Nadir At Five Years and Then Fully Normalize by the Second Decade in Allogeneic Stem Cell Transplantation Survivors
Natasha A Jain, MD, National Heart, Lung, and Blood Institute;
Libby Koklanaris, RN, National Heart, Lung, and Blood Institute;
Kamna Chawla, MD Pathology, MS Telecom and Computers, National Heart, Lung, and Blood Institute;
Priyanka A Pophali, M.D, National Heart, Lung, and Blood Institute;
Jeffrey K Klotz, M.D, National Heart, Lung, and Blood Institute;
Christopher S Hourigan, M.D, PhD, National Heart, Lung, and Blood Institute;
Bipin N Savani, MD, National Heart, Lung, and Blood Institute;
Sawa Ito, M.D, National Heart, Lung, and Blood Institute;
A. John Barrett, MD, National Heart, Lung, and Blood Institute;
Minoo Battiwalla, MD, MS, National Heart, Lung, and Blood Institute
Quality of Life in Patients Treated with Sirolimus and Tacrolimus for Prevention of GRAFT-Versus-HOST Disease
Heather Jim, PhD, Moffitt Cancer Center;
Anna Barata-Bardiella, Hospital Sant Pau;
Brent Small, PhD, University of South Florida;
Paul Jacobsen, PhD, Moffitt Cancer Center;
Claudio Anasetti, MD, Moffitt Cancer Center;
Joseph Pidala, MD, MS, Moffitt Cancer Center
A Population-Based Cohort Study of Second Malignancies and Late Mortality in Children Treated by Allogeneic Stem Cell Transplantation for Hematological Malignancies
Adam Stuart Nelson, MD, Sydney Children's Hospital;
Tracey Anne O'Brien, MD, Ctr Children's Cancer & Blood Disorders;
Renate Thielbeer, BSc, Children's Cancer Institute Australia for Medical Research;
Claire Vajdic, PhD, Adult Cancer Program;
Dr Anthony Dodds, MB BS FRACP FRCPA, St Vincents Hospital;
Leonie Wilcox, St Vincent's Hospital;
Leslie J Ashton, PhD, Molecular Epidemiology Group, Children’s Cancer Institute Australia for Medical Research
Association of Pre-Transplant Comorbidities with Long-Term Quality of Life (QOL) Among Survivors After Allogeneic Hematopoietic Cell Transplantation (HCT)
Mohamed L. Sorror, MD, Fred Hutchinson Cancer Research Center;
Jean C. Yi, PhD, Fred Hutchinson Cancer Research Center;
Barry Storer, PhD, Fred Hutchinson Cancer Research Center;
Emily E. Rock, MS, Fred Hutchinson Cancer Research Center;
Samantha B. Artherholt, PhD, Fred Hutchinson Cancer Research Center;
Rainer F. Storb, MD, University of Washington School of Medicine;
Paul J Martin, MD, Fred Hutchinson Cancer Research Center;
Karen L Syrjala, PhD, Fred Hutchinson Cancer Research Center
Ultra-Low Dose IL-2 Expands Natural Regulatory T Cells and CD56bright NK Cells in Patients and Healthy Donors and Is Associated with Clinical Improvement in Chronic Graft Versus Host Disease
Sawa Ito, M.D, National Heart, Lung, and Blood Institute;
Nancy Hensel, M.T., National Heart, Lung, and Blood Institute;
Minoo Battiwalla, MD, MS, National Heart, Lung, and Blood Institute;
Jan Melenhorst, BS, PhD, Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania;
Pawel Muranski, M.D., Ph.D., National Heart, Lung, and Blood Institute;
Samantha Miner, B.S., National Heart, Lung, and Blood Institute;
Kazushi Tanimoto, M.D., Ph.D., National Heart, Lung, and Blood Institute;
Fang Yin, M.D., National Heart, Lung, and Blood Institute;
Keyvan Keyvanfar, B.S., National Heart, Lung, and Blood Institute;
Libby Koklanaris, RN, National Heart, Lung, and Blood Institute;
Jeanine Superata, R.N., National Heart, Lung, and Blood Institute;
Jan Haggerty, R.N., National Heart, Lung, and Blood Institute;
Catherine M. Bollard, MD, Baylor College of Medicine, Texas Children's Hospital;
A. John Barrett, MD, National Heart, Lung, and Blood Institute
![[Visit Client Website]](images/banner.gif)